Regression of tamoxifen-stimulated massive uterine fibroid after conversion to anastrozole.
Attilakos
G
G
Division of Women's and Children's Health, Taunton & Somerset Hospital, Musgrove Park, Taunton TA1 5DA, UK.
Fox
R
R
D000368:Aged; D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D009570:Nitriles / Q000627:therapeutic use*; D012074:Remission Induction; D019233:Retreatment; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use*; D014463:Ultrasonography; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014230:Triazoles; D013629:Tamoxifen; D000077384:Anastrozole